The negative glucocorticoid regulation of CRH gene expression is a cri
tical control element in the hypothalamic-pituitary-adrenal axis. In t
his study, the molecular mechanisms mediating the glucocorticoid repre
ssion of cAMP-induced CRH-reporter expression in AtT-20 cells have bee
n examined, In these cells, dexamethasone decreases forskolin-induced
expression of CRH-reporter activity in a dose-dependent manner. This r
epression is mediated by the glucocorticoid receptor (GR) and does not
require ongoing protein synthesis, Several binding sites for the GR D
NA-binding domain were identified within the CRH 5'-flanking and 5'-un
translated regions utilizing in vitro DNase I protection assays. These
sites were independently mutated and/or deleted. Functional studies i
n transfected cells suggest that none of the protected DNA sequences m
ediate the glucocorticoid regulation and that the regulatory element(s
) mediating negative glucocorticoid regulation is contained within the
CRH DNA sequences from -248 to +4 bp relative to the major transcript
ion initiation site, To further localize the DNA sequence(s) responsiv
e to glucocorticoids, DNA fragments containing various amounts of huma
n CRH 5'flanking sequences were inserted 5' to the SV40 promoter. An 1
8-bp DNA fragment containing the CRH cAMP-responsive element is suffic
ient to confer both positive cAMP regulation and glucocorticoid repres
sion of cAMP-stimulated expression to the SV40 promoter. These results
suggest that glucocorticoid repression of forskolin-activated CRH-rep
orter expression in AtT-20 cells occurs via interference with the cAMP
-mediated activation of gene expression, possibly via direct or indire
ct interactions between the GR and the cAMP-responsive element-binding
proteins.